Found: 6
Select item for more details and to access through your institution.
Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2077, doi. 10.1007/s13555-024-01210-3
- By:
- Publication type:
- Article
Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn's Disease and Psoriasis.
- Published in:
- Genes, 2023, v. 14, n. 2, p. 445, doi. 10.3390/genes14020445
- By:
- Publication type:
- Article
Real world experience of brodalumab treatment in patients with moderate‐to‐severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15886
- By:
- Publication type:
- Article
Topical immunotherapy treatment of alopecia areata with diphenylcyclopropenone: Regulatory T cells as biomarkers for treatment response.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 7, p. 1, doi. 10.1111/dth.15522
- By:
- Publication type:
- Article
Sub‐population analysis of patients with plaque psoriasis treated with calcipotriol/betamethasone aerosol foam; effectiveness and patient satisfaction, according to baseline disease severity and prior psoriasis treatment experience, in a Greek population
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 6, p. 1, doi. 10.1111/dth.15484
- By:
- Publication type:
- Article
Real‐world data on the effectiveness of brodalumab in patients with moderate‐to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 6, p. 1121, doi. 10.1111/jdv.19816
- By:
- Publication type:
- Article